Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Fetzer Institute Supports Use of New Technology to Fight Disease

Abstract:
CytoViva Reveals Distinction Between Calcifying Nanoparticles and Inorganic Crystal

Research is finding evidence that may solve one of the great puzzles of 21st Century medicine using a new microscopy technology known as CytoViva.

Fetzer Institute Supports Use of New Technology to Fight Disease

AUBURN, AL | Posted on February 9th, 2007

Researchers at Mayo Clinic successfully isolated nanoparticles from
human kidney stones and calcified aortas. The findings, which appear in the
Journal of Investigative Medicine, are significant because they move
researchers a step closer to understanding whether nanoparticles can
contribute to the pathogenesis of a variety of diseases. Recently, for the
first time the Mayo Clinic investigators visualized their nanoparticle
isolates in real-time using CytoViva.

In November, a team of scientists at Nanobac Pharmaceuticals utilizing
CytoViva released the first-ever live video footage of calcifying
nanoparticles. Calcification occurs in many diseases listed on the leading-
cause-of-death list such as cardiovascular and kidney disease.
Calcification is also linked to chronic inflammation in atherosclerosis and
end-stage renal disease, but it is unclear how this occurs. Nanoparticle
calcification is being studied because it is believed to play a basic role
in calcifying diseases ranging from heart disease to kidney stones to
prostate disease.

"We used a new, very high definition microscope system," explained Dr.
Neva Ciftcioglu, Science Director of Nanobac Pharmaceuticals, which
produced the video. "Before these technologies were created recently, we
had to chemically treat the nanoparticles to see below the 200 nanometer
threshold, which kept us from observing live processes."
The new video was first unveiled at a recent invitation-only Auburn
University conference of leading microscopy and biomedical scientists,
organized by the Fetzer Memorial Trust. Fetzer specializes in supporting
leading-edge medical technologies and has been collaborating with Nanobac
Pharmaceuticals on this project since early 2006.

CytoViva, which won an R&D 100 award last year, is a new product
combining fluorescence and high resolution optical imaging to create a new,
unparalleled level of microscopy performance. The unique system allows
researchers to view both fluorescent and non-fluorescent sample structure
simultaneously, in real time and at high resolution.

####

About CytoViva, Inc.
Auburn, AL-based, CytoViva, Inc., is a subsidiary of Aetos
Technologies, Inc., a privately held technology development company founded
to bridge the gap between university-based research and the commercial
market.

For more information, please click here

Contacts:
Bronwen Murray
(334) 737-3125
http://www.cytoviva.com

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Vegetable oil ingredient key to destroying gastric disease bacteria: In mice, therapeutic nanoparticles dampen H. pylori bacteria and inflammation that lead to ulcers and gastric cancer November 25th, 2014

Research reveals how our bodies keep unwelcome visitors out of cell nuclei November 24th, 2014

ASU, IBM move ultrafast, low-cost DNA sequencing technology a step closer to reality November 24th, 2014

An Inside Job: UC-Designed Nanoparticles Infiltrate, Kill Cancer Cells From Within November 24th, 2014

Announcements

Renishaw receives Queen's Award for spectroscopy developments November 25th, 2014

JPK reports on the use of AFM and the CellHesion module to study plant cells at the University of Queensland November 25th, 2014

Vegetable oil ingredient key to destroying gastric disease bacteria: In mice, therapeutic nanoparticles dampen H. pylori bacteria and inflammation that lead to ulcers and gastric cancer November 25th, 2014

Research yields material made of single-atom layers that snap together like Legos November 25th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More












ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE